Broader Detection of RAS Mutations by GeneStrat NGS™ Test & their Association with Other Prognostic Markers

Time: 11:00 am
day: Day Two


  • High concordance between GeneStrat® targeted (ddPCR) and GeneStrat NGS™ test measuring KRAS in blood
  • Real-world detection of RAS variants in patients with NSCLC
  • Relationship between a proteomic host immune classifier and tumor mutations in the RAS pathway